Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
AiYu capsule
- Development stage
- Phase 4
- Lead developer
- Guizhou Yibai Pharmaceutical
- Administration
- Oral
01
Overview
AiYu capsule is a traditional Chinese medicine undergoing clinical investigation for its efficacy and safety in various cancer-related conditions. It has been studied in combination with chemotherapy for malignant lymphoma and non-small cell lung cancer. Additionally, it is being evaluated for the treatment of chemotherapy-related myelosuppression, specifically leukopenia, in patients with gastric cancer, colorectal cancer, ovarian cancer, and lymphoma.
- Other names
- AiYu艾愈艾愈胶囊
Beyond the preview
Go deeper on AiYu capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AiYu capsule.